VCYT
Veracyte Inc
39.80$
-1.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.5% | 43.4% | 39.1% | 39.2% | 36.0% | 30.3% | 35.3% | 33.9% | 34.3% | 31.3% | 33.1% | 30.4% | |
| 56.5% | 56.6% | 60.9% | 60.8% | 64.0% | 69.7% | 64.7% | 66.1% | 65.7% | 68.7% | 66.9% | 69.6% | |
| 25.7% | 25.8% | 23.5% | 19.3% | 16.1% | 12.3% | 14.6% | 13.6% | 13.7% | 15.9% | 15.5% | 13.7% | |
| 49.4% | 45.6% | 36.5% | 32.1% | 26.0% | 24.1% | 31.3% | 46.2% | 25.8% | 43.7% | 40.0% | 21.4% | |
| 132.5% | 124.2% | 105.1% | 97.7% | 88.2% | 82.2% | 94.8% | 103.4% | 79.6% | 92.5% | 63.3% | 55.3% | |
| -76.0% | -67.6% | -44.3% | -36.9% | -24.2% | -12.6% | -30.1% | -37.3% | -13.9% | -23.8% | 3.6% | 14.3% | |
| 1.1% | 0.8% | 4.2% | 6.9% | 2.1% | 0.6% | 0.2% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | |
| -76.9% | -68.1% | -48.2% | -43.1% | -25.0% | -10.5% | -29.7% | -37.2% | -12.3% | -21.2% | 5.8% | 13.2% | |
| -1.7% | 1.0% | 4.5% | 7.5% | 1.3% | 3.2% | 0.8% | -2.8% | 0.0% | -0.6% | 0.4% | 0.4% | |
| -76.9% | -68.1% | -48.2% | -43.1% | -25.0% | -10.5% | -29.7% | -34.4% | -12.3% | -20.6% | 5.4% | 12.8% | |
| -75.8% | -65.7% | -38.5% | -33.0% | -18.6% | -6.5% | -22.8% | -27.4% | -2.4% | -13.7% | 11.0% | 17.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.